Cow’s milk allergy in infancy has serious impact on both the baby and the mother. The cow’s milk allergic baby suffers from problems like eczema, wheezing, diarrhea, reflux and extreme vomiting, leaving its mother puzzled with worries regarding her baby’s health and growth performance. There is a strong trend that children who suffered from cow’s milk allergy in infancy develop asthma, hay fever or dermatitis to inhalant allergens later in life. This emphasizes the importance of reducing the risk of development of cow’s milk allergy in early life. Replacing standard infant formulas by formulas based on protein hydrolysates offers the solution for most babies with cow’s milk allergy. These hydrolysates need to be of consistent high quality, meeting all safety requirements for hypo-allergenic infant formulas. This presentation will discuss the prevalence and mechanism of cow’s milk allergy in infancy and how hydrolysates work in the risk reduction of cow’s milk allergy.
Nutrition & Regulatory Affairs Manager
After graduating in Human Nutrition at Wageningen University and Research Centre in the absorption and metabolism of bio-active flavonoids, Marjan further investigated the effects of bio-active components on bone metabolism (Numico Research). As Scientific policy manager Nutrition and Health at Product Board Margarine, Fats and Oils (MVO) Marjan translated research, policy and legislation developments to tailored information for companies in the oils and fat industry and lobbied for these companies both on national (Ministry of Health) as well as European (Brussels) level. Within FrieslandCampina Domo her focus is on the nutritional and immunological aspects of ingredients for infant nutrition, like hydrolysates, lactoferrin and galacto-oligosaccharides.
Infant and Medical Nutrition Applications Specialist
Maria holds a Food Science degree (BSc) from University College Cork Ireland after which she joined Kerry Ingredients and Flavours working as an application specialist in the food and medical nutrition markets both in Ireland and The Netherlands. In 2009 Maria continued her interest in the dairy industry joining FrieslandCampina Domo as application lead in the medical and infant nutrition markets. Maria’s focus is on the functionality of our products in infant and medical nutrition working in close collaboration with customers in the development of new products.
Rick de Waard
Growth Initiatives Manager
Rick de Waard is active for FrieslandCampina Domo as Growth Initiatives Manager (Product Management and Marketing) for the product portfolio hydrolysates. In this role he is strongly focused on marketing, innovation, production and commercialization of hydrolysates in the infant nutrition and biopharmaceutical markets. Rick has significant experience in food related innovation and business in both academic and B2B industrial settings: MSc in Medical Biology, PhD in Immunology (immunomodulatory effects of probiotics) and >10 years active in the dairy industry.
Global Marketing Manager
Trained as a biochemist (MsC) at Wageningen Research Centre, held various positions in R&D. Passionate about innovation, later in his career switched to a position in marketing to complete the necessary skills to successfully bring innovations to customers and consumers. Worked with partners around the globe to bring innovations to the market as fast as possible in segments like infant-, medical- and sports nutrition, dietary supplements and functional foods.
Starts 8:00 am in New York | 5:00 am in Los Angeles | 2:00 pm in Paris
October 02nd, 2012